{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:49Z","timestamp":1793060029955,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Hepatitis E is an infectious disease due to inflammation of the liver caused by hepatitis E virus (HEV) and represents one of the most common causes of acute hepatitis and jaundice in the world. Although data of hepatitis E infection in patients with rheumatoid arthritis (RA) are accumulating, little is known on the course of HEV infection. We reported, for the 1st time, a case of patient with RA with hepatitis E that developed during leflunomide therapy in combination with low-dose steroids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We present a 39-year-old woman, affected by RA and treated with leflunomide, reported diffuse itching and persistent fatigue laboratory data revealed elevated liver enzyme levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Positivity for anti-HEV IgM and IgG was observed. HEV-RNA of the genotype 3 was detected, indicating acute E hepatitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions and outcomes:<\/jats:title>\n            <jats:p>Leflunomide was stopped and restarted 5 months after the initial diagnosis at the same dosage, with a close clinical and laboratory follow-up. The virus was eradicated from the serum without chronic transformation. The patient is alive and well 7 months after the initial diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>To our knowledge, this report is the 1st case of acute E hepatitis in a patient with RA developed during leflunomide therapy in combination with low-dose steroids. Moreover, geoepidemiology of infection is important, due to the fact that Abruzzo, a central region of Italy, has the highest HEV seroprevalence in general population, related to the zoonotic transmission of the infection from domestic and wild animals. Our case highlighted that immunosuppressive therapy, and in particular leflunomide, could be safely reintroduced after the resolution of the infection and the clearance of the virus. Further studies are needed to evaluate potential advantages in serologic testing for HEV infection as a part of the routine workup done to patients with rheumatic diseases and selected for immunosuppressive therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000016399","type":"journal-article","created":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T14:44:21Z","timestamp":1565880261000},"page":"e16399","source":"Crossref","is-referenced-by-count":8,"title":["Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide"],"prefix":"10.1097","volume":"98","author":[{"given":"Francesco","family":"Carubbi","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Department of Biotechnological and Applied Clinical Science, School of Medicine, University of L\u2019Aquila"},{"name":"Department of Medicine, ASL1 Avezzano-Sulmona-L\u2019Aquila"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Picchi","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, S. Salvatore Hospital, L\u2019Aquila, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Di Bartolomeo","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Biotechnological and Applied Clinical Science, School of Medicine, University of L\u2019Aquila"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ricciardi","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, S. Salvatore Hospital, L\u2019Aquila, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Biotechnological and Applied Clinical Science, School of Medicine, University of L\u2019Aquila"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Marola","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, S. Salvatore Hospital, L\u2019Aquila, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Grimaldi","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, S. Salvatore Hospital, L\u2019Aquila, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Biotechnological and Applied Clinical Science, School of Medicine, University of L\u2019Aquila"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","first-page":"376","article-title":"Hepatitis E: a literature review","volume":"5","author":"Guerra","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrgastro.2017.150","article-title":"Hepatitis E virus: advances and challenges","volume":"15","author":"Nimgaonkar","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis E virus infection","volume":"68","author":"Dalton","year":"2018","journal-title":"J Hepatol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"NEJM"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MOT.0000000000000432","article-title":"Hepatitis E viral infection in solid organ transplant patients","volume":"22","author":"Fang","year":"2017","journal-title":"Curr Opin Organ Transplant"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcv.2016.05.006","article-title":"Hepatitis E virus infection in the HIV-positive patient","volume":"80","author":"Debes","year":"2016","journal-title":"J Clin Virol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/bjh.15133","article-title":"Hepatitis E virus - key points for the clinical haematologist","volume":"181","author":"O\u2019Gorman","year":"2018","journal-title":"Br J Haematol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/24725625.2017.1288344","article-title":"Type-E hepatitis in rheumatoid arthritis patients","volume":"1","author":"Kobayashi","year":"2017","journal-title":"Mod Rheumatol Case Rep"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/liv.13037","article-title":"Extrahepatic manifestations of hepatitis E virus","volume":"36","author":"Kamar","year":"2016","journal-title":"Liver Int"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jhep.2016.11.016","article-title":"Hepatitis E virus: Infection beyond the liver?","volume":"66","author":"Pischke","year":"2017","journal-title":"J Hepatol"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/practneurol-2016-001588","article-title":"Hepatitis E virus and neurological disorders","volume":"17","author":"Mclean","year":"2017","journal-title":"Pract Neurol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.rdc.2017.09.005","article-title":"Gastrointestinal and hepatic disease in rheumatoid arthritis","volume":"44","author":"Craig","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00296-018-4021-5","article-title":"Clinical connection between rheumatoid arthritis and liver damage","volume":"38","author":"Radovanovi\u0107-Dini\u0107","year":"2018","journal-title":"Rheumatol Int"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"E211","DOI":"10.3390\/v8080211","article-title":"Hepatitis E seroprevalence in Europe: a meta-analysis","volume":"8","author":"Hartl","year":"2016","journal-title":"Viruses"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jiph.2017.08.004","article-title":"Hepatitis E in Italy: a silent presence","volume":"11","author":"Mauceri","year":"2018","journal-title":"J Infect Public Health"},{"key":"R18-20230914","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.30.30299","article-title":"High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014","volume":"21","author":"Lucarelli","year":"2016","journal-title":"Euro Surveill"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.dld.2016.06.035","article-title":"Hepatitis E in a region of Italy: an emerging autochthonous infection?","volume":"48","author":"Tarantino","year":"2016","journal-title":"Dig LiverDis"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s10067-007-0595-0","article-title":"Acute polyarthritis revealing hepatitis E","volume":"26","author":"Serratrice","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R21-20230914","first-page":"6873276","article-title":"Hepatitis E during tocilizumab therapy in a patient with rheumatoid arthritis: case report and literature review","volume":"2018","author":"Ikeuchi","year":"2018","journal-title":"Case Rep Rheumatol"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1097\/MD.0000000000000675","article-title":"Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study","volume":"94","author":"Bauer","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"e9407","DOI":"10.1097\/MD.0000000000009407","article-title":"Course of hepatitis E infection in a patient with rheumatoid arthritis and autoimmune hepatitis: a case report","volume":"96","author":"Thodou","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jhep.2008.11.007","article-title":"Chronic hepatitis E in the immunosuppressed: a new source of trouble?","volume":"50","author":"Bihl","year":"2009","journal-title":"J Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201908160-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T22:00:12Z","timestamp":1694728812000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201908160-00001"}},"subtitle":["A case report with emphasis on geoepidemiology"],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":24,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000016399","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}